Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia

Sarosiek, S; Sermer, D; Branagan, AR; Treon, SP; Castillo, JJ

Castillo, JJ (通讯作者),Dana Farber Canc Inst, Bing Ctr Waldenstrom Macroglobulinemia, Boston, MA 02115 USA.

EXPERT REVIEW OF ANTICANCER THERAPY, 2022; 22 (5): 471

Abstract

Introduction The development of Bruton tyrosine kinase (BTK) inhibitors has significantly changed the treatment landscape for patients with Waldenstro......

Full Text Link